You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas: Allergy
3 March 2023 - - US-based pharmaceutical company Bryn Pharma LLC has posted positive pharmacokinetic/pharmacodynamic (PK/PD) and safety data for its investigational 13.2mg intranasal epinephrine spray...
2 March 2023 - - US-based Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) has posted interim results from Part 1 of AROC3-1001, an ongoing Phase 1/2 clinical study of ARO-C3, the company's investig...
28 February 2023 - - Israel-based Teva Pharmaceutical Industries Ltd's (NYSE: TEVA) (TASE: TEVA) Teva Pharmaceuticals USA, Inc US affiliate has presented new data on its Digihaler System at ...
28 February 2023 - - US-based biopharmaceutical company Astria Therapeutics, Inc. (NASDAQ: ATXS) presented new STAR-0215 data in two poster presentations at the American Academy of Allergy, Asthm...
6 February 2023 - - US-based lung health management platform Aluna has completed a USD 15.3m series B round of financing to continue growing its solution among doctors and patients managing asthma, cy...
3 February 2023 - Danish pharmaceutical company ALK-Abelló A/S (ALK) (CPH:ALK-B) reported on Friday that its Biologics License Application (BLA) for its house dust mite (HDM) sublingual allergy...
Related Headlines
Loreaux, Humphries Named to Bryn Pharma Board of Directors
AcuCort signs exclusive commercial agreement with Kamada
MediPrint Ophthalmics Has Initiated Its SIGHT-2 Phase 2b Clinical Study for Its Lead Asset
DC4U and LUMC consortium receives grant to jointly develop Type I diabetes treatment